Orchestra BioMed Holdings, Inc.
Develops bioelectronic & drug/device therapies for hypertension and artery disease.
OBIO | NDAQ
Overview
Corporate Details
- ISIN(s):
- KYG4411D1097 (+1 more)
- LEI:
- Country:
- United States of America
- Address:
- 150 UNION SQUARE DRIVE, 18938 NEW HOPE
- Website:
- http://www.orchestrabiomed.com
- Sector:
- Manufacturing
- Industry:
- Manufacture of medical and dental instruments and supplies
Description
Orchestra BioMed Holdings, Inc. is a biomedical innovation company developing therapeutic products for significant unmet needs in procedure-based medicine. The company's strategy focuses on accelerating high-impact technologies to patients through risk-reward sharing partnerships with leading medical device companies. Its flagship investigational products include Atrioventricular Interval Modulation (AVIM) Therapy, a bioelectronic treatment designed for hypertension, and the Virtue® Sirolimus AngioInfusion™ Balloon (SAB), a drug/device combination product candidate for treating artery disease without a permanent implant.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Orchestra BioMed Holdings, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Orchestra BioMed Holdings, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Orchestra BioMed Holdings, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
